Steven I. Hirschfeld

Pediatrics

31 Center Dr Rm 2A3
Bethesda, MD 20892

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLC.

ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLC.

Journal: Clinical lung cancer

Published: October 30, 2025

Addressing the Health Care Needs of Displaced Populations Following a Disaster: Development of Clinical Tools and Tracking Methods.

Addressing the Health Care Needs of Displaced Populations Following a Disaster: Development of Clinical Tools and Tracking Methods.

Journal: Disaster medicine and public health preparedness

Published: September 04, 2025

Addressing the Healthcare Needs of Displaced Populations with Chronic Illness Following a Disaster: Examples from the US Public Health Service Federal Medical Station Experience.

Addressing the Healthcare Needs of Displaced Populations with Chronic Illness Following a Disaster: Examples from the US Public Health Service Federal Medical Station Experience.

Journal: Disaster medicine and public health preparedness

Published: September 04, 2025

First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors.

First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors.

Journal: Journal for immunotherapy of cancer

Published: July 16, 2025

Commentary on Hey, Hunter, Muller et al. A Never-ending Story: Evaluating Evidence in Medicinal Product Decision Making.

Commentary on Hey, Hunter, Muller et al. A Never-ending Story: Evaluating Evidence in Medicinal Product Decision Making.

Journal: Clinical therapeutics

Published: January 26, 2024

INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.

INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.

Journal: Cancer immunology, immunotherapy : CII

Published: August 31, 2023

Editorial: Outcome assessments for longitudinal studies in pediatric research.

Editorial: Outcome assessments for longitudinal studies in pediatric research.

Journal: Frontiers in pediatrics

Published: February 25, 2022

Designing a Visit Schedule for Longitudinal Studies in Pediatric Research.

Designing a Visit Schedule for Longitudinal Studies in Pediatric Research.

Journal: Frontiers in pediatrics

Published: February 25, 2022

Principles of Researching Health Disparities in Longitudinal Cohort Studies Enrolling Children.

Principles of Researching Health Disparities in Longitudinal Cohort Studies Enrolling Children.

Journal: Frontiers in pediatrics

Published: November 09, 2020

NCS Assessments of the Motor, Sensory, and Physical Health Domains.

NCS Assessments of the Motor, Sensory, and Physical Health Domains.

Journal: Frontiers in pediatrics

Published: October 28, 2020

Health Measurement Model-Bringing a Life Course Perspective to Health Measurement: The PRISM Model.

Health Measurement Model-Bringing a Life Course Perspective to Health Measurement: The PRISM Model.

Journal: Frontiers in pediatrics

Published: September 13, 2020

Challenges in clinical trials for children and young people.

Challenges in clinical trials for children and young people.

Journal: Archives of disease in childhood

Published: February 07, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026